GLY-30425-34136
1 vaccination
2 coded responses
12 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 604 / IL
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-24
Registered in v-safe
-
2021-02-24
Dose 1 — Pfizer-BioNTech
-
2021-02-25
Survey response — days 1–6 daily, dose 1MedDRA: Pain — Feeling: Good · Site: SwellingFree text: Just mild soreness at shot site last night and this morningMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-10
- 2021-03-17
- 2021-05-26
- 2021-08-25
-
2022-02-24
Survey response — 12 months, dose 1MedDRA: Loop electrosurgical excision procedure, Precancerous cells present, Pulmonary thrombosis, Surgery, Uterine dilation and curettage — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Symptoms: Blood clots in lungs in Oct. Level 3 pre-cancer cells found in cervix. Had Leep and D&C three weeks ago. Looks all clear now · Healthcare visit (other): SurgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-02-24
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-02-25
-
2022-02-25
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-24 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-24 | Successful 2022-02-25 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Just mild soreness at shot site last night and this morning
Release 11 — 12 months, dose 1
Symptoms: Blood clots in lungs in Oct. Level 3 pre-cancer cells found in cervix. Had Leep and D&C three weeks ago. Looks all clear now
Healthcare visit (other): Surgery
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Surgery | · | · | ✓ |
| SD | Loop electrosurgical excision procedure | · | · | ✓ |
| SD | Precancerous cells present | · | · | ✓ |
| SD | Pulmonary thrombosis | · | · | ✓ |
| SD | Uterine dilation and curettage | · | · | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release